.svg)
%20(1).jpg)
Shelf life is a defining quality attribute for any pharmaceutical product. For oral thin strips, however, it is uniquely delicate. Their ultra-thin structure, high surface exposure, and sensitive formulation make them far more vulnerable to environmental stress than conventional dosage forms.
For an oral strips manufacturer, packaging is an active stability system. It protects the formulation from moisture, oxygen, and light, while preserving mechanical integrity and therapeutic performance.
This becomes even more critical when supplying regulated and export markets, where stability expectations are strict, and shelf life claims must be supported by robust data. In these environments, packaging decisions directly influence regulatory approval, product reliability, and commercial viability.
Oral dissolving film strips differ fundamentally from tablets and capsules. Their thin polymer matrices contain low-dose APIs distributed across a wide surface area, making them more exposed to environmental conditions.
Even minor exposure to moisture or oxygen can trigger degradation, reduce API potency, or alter strip flexibility.
An oral strips manufacturer frequently encounters stability failures linked not to formulation limitations, but to packaging inefficiencies. Common triggers include:
These risks highlight why packaging plays a central role in maintaining shelf life.
Packaging functions as the first and most important line of defence against environmental threats.
It isolates oral dissolving film strips from:
Prevents oxidative degradation of sensitive APIs.
Maintains structural integrity and prevents hydrolysis.
Protects light-sensitive compounds from photodegradation.
Ensures product safety throughout storage and distribution.
Even a well-designed formulation can fail stability requirements if packaging fails to provide sufficient protection. This makes packaging selection a strategic decision for every oral strips manufacturer targeting global markets.
Barrier performance determines how effectively packaging protects oral thin strips from environmental exposure.
High-barrier laminates, typically composed of multiple protective layers, provide significantly better protection than standard plastics.
Two key performance indicators are central to this evaluation :
The first is MVTR (Moisture Vapour Transmission Rate), which measures the rate of moisture penetration. The second is OTR (Oxygen Transmission Rate), which measures oxygen permeability.
Lower MVTR and OTR values indicate stronger protective performance and longer shelf life potential.
For oral dissolving film strips, selecting materials with excellent barrier properties ensures consistent stability across diverse climate zones.
Packaging materials must also remain chemically compatible with the product.
Poor material selection can cause:
These interactions can compromise efficacy, safety, and regulatory compliance.
An experienced oral strips manufacturer evaluates packaging compatibility through rigorous stability testing to prevent such risks.
Oxygen exposure can significantly impact the stability of oral thin strips, particularly when APIs are oxidation-sensitive.
Packaging formats designed to minimise oxygen ingress include:
High-barrier sachets
Multi-layer laminates provide strong protection against oxygen penetration.
Blister packaging systems
Individual cavity protection reduces overall exposure.
Both formats ensure minimal oxygen transmission while supporting safe handling and transport.
Seal integrity also plays a critical role. Even high-performance materials cannot maintain stability if the sealing quality is compromised.
Poor seals cause gradual oxygen ingress, leading to progressive degradation over the product’s shelf life.
Moisture represents the single greatest threat to the stability of oral dissolving film strips.
Even minimal moisture exposure can cause:
To address this, oral strips manufacturers implement several protective strategies.
These materials prevent humidity penetration.
Desiccants absorb residual moisture within packaging systems.
Packaging under controlled humidity conditions prevents moisture introduction during manufacturing.
Climate variability across global supply chains further increases the importance of moisture-resistant packaging. Products may move through humid tropical environments or dry storage conditions, making barrier protection essential for stability.
Many APIs used in oral thin strips are sensitive to UV and visible light.
Light exposure can trigger:
The right packaging solutions address these risks using:
While transparent packaging may improve visual appeal, it often compromises stability protection.
An oral strips manufacturer prioritises protective performance over aesthetics when designing packaging for regulated markets.
Sustainability has become an important priority across the pharmaceutical industry. However, balancing sustainability and stability remains a complex challenge.
Oral thin films play an important role in improving patient adherence, particularly in paediatric and geriatric care.
However, sustainable packaging presents specific technical challenges for oral thin strips. Many recyclable and biodegradable materials, particularly mono-material plastics and paper-based laminates, typically provide lower resistance to moisture and oxygen compared to conventional multi-layer aluminium laminates.
This can increase the risk of moisture ingress, oxidation, strip deformation, and reduced API stability, especially in humid climates or long export supply chains.
For an oral strips manufacturer, this creates a direct trade-off. Packaging must support environmental objectives while maintaining the barrier performance required to preserve shelf life, potency, and structural integrity.
New material innovations are helping bridge this gap. High-performance recyclable laminates and advanced coating technologies now offer improved MVTR and OTR performance while supporting sustainability objectives. However, these materials still require extensive compatibility and stability testing under real-world storage conditions.
Ultimately, sustainability decisions must follow stability requirements. An oral strips manufacturer must prioritise patient safety, regulatory compliance, and shelf life assurance, while adopting sustainable packaging only where it delivers equivalent protective performance.
Regulatory agencies evaluate packaging as an integral part of stability and shelf life determination.
Packaging directly influences:
Regulated markets expect packaging systems to demonstrate reliable protection throughout the product’s labelled shelf life.
Regulatory inspections also review packaging design, material selection, and stability performance as part of compliance assessments.
For an oral strips manufacturer, packaging decisions therefore affect not only stability but also approval timelines and global market access.
Strong packaging systems support consistent product quality, regulatory compliance, and long-term reliability across diverse markets.
To learn how ZIM Labs can support your oral thin strip development and packaging strategy, connect with our experts to discuss your formulation and stability requirements.
ZIM Laboratories Limited is a therapy-agnostic and innovative drug delivery solution provider focusing on enhancing patient convenience and treatment adherence to drug intake. We offer a range of technology-based drug delivery solutions and non-infringing proprietary manufacturing processes to develop, manufacture, and supply innovative and differentiated generic pharmaceutical products to our customers globally. At ZIM Labs, we provide our customers with a comprehensive range of oral solid value-added, differentiated generic products in semi-finished and finished formulations. These include granules, pellets (sustained, modified, and extended-release), taste-masked powders, suspensions, tablets, capsules, and Oral Thin Films (OTF).
